Subcutaneous Drug Delivery Devices Market Analysis Report By Product, By Distribution Channel, By Region And Segment Forecasts From 2020 To 2027

Industry Insights

The global subcutaneous drug delivery devices market size was accounted for USD 21.2 billion in 2019. It is also estimated to witness a 10.4% CAGR over the forecasted period, 2020 to 2027. The rising prevalence of cardiovascular diseases(CVD) and diabetes among the millennial population are expected to drive market growth.

A report by IDF (International Diabetes Federation) stated that the number of diabetic individuals is projected to be around 48.0% annually from 2017 to 2045. It also stated that this number would be on the higher side across developing regions as compared to the developed ones. Moreover, adults having type 2 diabetes are more susceptible to CVD, which is also being considered as one of the major factors for the demand for subcutaneous drug delivery devices.       

The rising adoption of such devices has reduced the number of needle stick injuries and dosage errors. Thus, good treatment adherence is being observed among the patients over the usage of such devices. Also, the surging popularity of needle-free injectors and the decreasing number of injuries associated with them are estimated to trigger the market demand for such devices.

Product Insights

In 2019, the product segment of pen injectors held the largest share of around 38.0% across the global subcutaneous drug delivery devices market. The rising number of product approvals, higher social acceptance, affordability, and enhanced product design are projected to drive the market growth for this segment. Moreover, reduced medical spending and reduction in the usage of injections are further expected to fuel up market growth.

The segment of wearable injectors is estimated to witness the fastest growth in the upcoming years. Surging preference of bolus injectors or patch pumps by physicians for administrating higher-volume and viscosity biological drugs are anticipated to contribute majorly towards the market growth.

Distribution Channel Insights

In 2019, the retail pharmacies distribution channel segment held a dominant share of more than 44.9% across the global market. Rising self-administration and patient awareness have contributed majorly to the growth of this segment. Also, the ease of availability of such devices even in remote locations across the globe is expected to boost the market growth.

The segment of online pharmacies is anticipated to register the highest CAGR over the forecasted period. This growth can be associated with the discounts and offers provided by the vendors over the online purchase of their products.  For example, Eli Lilly had partnered with Express Scripts in 2017 for offering a discount on their products across web and mobile platforms.

Regional Insights

North America accounted for a dominant share of around 44.1% across the global subcutaneous drug delivery devices market in 2019. It is also projected to dominate the market in the upcoming years. This can be associated with the rapid development of health infrastructure and several initiatives undertaken by the key players residing across this region to retain their market share. Further, the rising prevalence of diseases such as cardiovascular diseases, multiple sclerosis, arthritis, and diabetes is anticipated to augment the market growth for this region.

The Asia Pacific is expected to witness significant growth across the global market from 2020 to 2027. This growth can be attributed to the increasing number of diabetic patients across this region. A report by IDF (International Diabetes Federation) stated that around 60.0% of the diabetic population across the globe resides in Asia. These factors are anticipated to trigger the market demand for such devices in the upcoming years.

COVID-19 Impact Insights

The market has been positively impacted due to the ongoing COVID-19 pandemic. The need for contactless drug delivery in the body of patients is expected to drive the market demand for such devices. As the development of the vaccine is still under the trial phase, the need for delivering several drugs inside the human body as per the requirement is becoming a tedious task to the doctors. As individuals having diabetes and CVDs are considered under the high-risk category by the WHO, less exposure to their skin while providing medication is the prime focus of the doctors. Thus, the usage of such devices is gaining traction across the globe. Moreover, rapid technological advances being undertaken by the key players for promoting the usage of their products and increasing the budget of the healthcare sector are expected to trigger market growth over the post-pandemic period.

Subcutaneous Drug Delivery Devices Market Share Insights

The key players operating in the market are Gerresheimer AG, Ypsomed AG, Medtronic Plc, Novo Nordisk, Insulet Corporation, Elcam Medical Group, Unilife Corporation, Inolife Sciences, and PharmaJet.The market is getting fragmented due to the surging number of medium and large-scale vendors offering such devices.

Constant product development and innovation are being undertaken by these players for widening their global reach and product portfolio. Also, strategies like acquisitions, mergers, and product launches are being undertaken by them to gain a competitive advantage over other players.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2016 to 2027 in each of the sub-segments. For this study, Million Insights has segmented the global subcutaneous drug delivery devices market based on product, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2027)
    • Prefilled syringes
    • Pen injectors
    • Auto-injectors
    • Wearable injectors
    • Needle-free injectors

• Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)
    • Hospital pharmacies
    • Retail pharmacies
    • Online pharmacies

• Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
        • The U.S.
        • Canada
    • Europe
        • The U.K.
        • Germany
        • France
        • Italy
        • Spain
    • The Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
    • Latin America
        • Brazil
        • Mexico
        • Argentina
        • Colombia
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE